US Stock MarketDetailed Quotes

VVOS Vivos Therapeutics

Watchlist
  • 4.8558
  • -0.0942-1.90%
Trading Dec 17 10:24 ET
23.48MMarket Cap-0.97P/E (TTM)

Vivos Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
16.93%3.86M
19.41%4.05M
-11.36%3.42M
-13.87%13.8M
-17.77%3.25M
-22.26%3.3M
-18.86%3.4M
5.85%3.86M
-5.10%16.02M
-10.10%3.95M
Operating revenue
16.93%3.86M
19.41%4.05M
-11.36%3.42M
-13.87%13.8M
-17.77%3.25M
-22.26%3.3M
-18.86%3.4M
5.85%3.86M
-5.10%16.02M
-10.10%3.95M
Cost of revenue
-1.80%1.53M
8.17%1.4M
-2.50%1.48M
-7.91%5.53M
-25.99%1.16M
-11.20%1.55M
-18.73%1.3M
39.07%1.52M
40.27%6.01M
21.68%1.57M
Gross profit
33.60%2.33M
26.36%2.65M
-17.12%1.94M
-17.45%8.27M
-12.37%2.09M
-30.01%1.75M
-18.93%2.1M
-8.39%2.34M
-20.51%10.02M
-23.27%2.38M
Operating expense
-7.57%4.98M
-30.66%4.59M
-22.06%5.72M
-27.06%25.57M
-26.34%6.22M
-31.84%5.39M
-30.75%6.62M
-20.11%7.34M
9.28%35.05M
-12.07%8.45M
Selling and administrative expenses
-7.71%4.83M
-31.31%4.44M
-22.20%5.58M
-27.44%24.95M
-26.64%6.07M
-32.23%5.24M
-31.13%6.47M
-20.61%7.17M
9.70%34.38M
-12.30%8.28M
-Selling and marketing expense
-46.02%346K
-45.76%320K
3.97%655K
-53.80%2.47M
-55.28%606K
-42.04%641K
-65.27%590K
-16.33%630K
-3.80%5.34M
2.89%1.36M
-General and administrative expense
-2.37%4.49M
-29.86%4.12M
-24.72%4.92M
-22.60%22.48M
-21.03%5.47M
-30.59%4.6M
-23.59%5.88M
-21.00%6.54M
12.60%29.04M
-14.76%6.92M
Depreciation amortization depletion
-2.67%146K
-2.03%145K
-16.57%146K
-7.17%621K
-11.83%149K
-14.29%150K
-8.64%148K
8.02%175K
-8.73%669K
0.60%169K
-Depreciation and amortization
-2.67%146K
-2.03%145K
-16.57%146K
-7.17%621K
-11.83%149K
-14.29%150K
-8.64%148K
8.02%175K
-8.73%669K
0.60%169K
Operating profit
27.34%-2.65M
57.14%-1.94M
24.38%-3.79M
30.90%-17.3M
31.83%-4.13M
32.68%-3.64M
35.14%-4.52M
24.61%-5.01M
-28.56%-25.03M
6.72%-6.06M
Net non-operating interest income expense
Other net income (expense)
-98.13%29K
100.59%6K
-99.33%22K
213.07%3.71M
-384.62%-126K
5,829.63%1.55M
-3,510.71%-1.01M
152.45%3.3M
247.70%1.19M
97.04%-26K
Gain on sale of security
----
----
----
--3.78M
---131K
--1.6M
---867K
--3.18M
----
----
Special income (charges)
----
----
----
--0
----
----
----
----
241.27%1.29M
102.41%22K
-Less:Other special charges
----
----
----
----
----
----
----
----
---1.29M
---22K
Other non- operating income (expenses)
154.72%29K
104.17%6K
-82.68%22K
35.64%-65K
110.42%5K
-96.30%-53K
-414.29%-144K
504.76%127K
-193.52%-101K
-250.00%-48K
Income before tax
-24.99%-2.62M
65.09%-1.93M
-120.96%-3.76M
43.04%-13.58M
30.05%-4.26M
61.48%-2.09M
20.94%-5.53M
68.05%-1.7M
-17.53%-23.85M
17.64%-6.09M
Income tax
Net income
-24.99%-2.62M
65.09%-1.93M
-120.96%-3.76M
43.04%-13.58M
30.05%-4.26M
61.48%-2.09M
20.94%-5.53M
68.05%-1.7M
-17.53%-23.85M
17.64%-6.09M
Net income continuous Operations
-24.99%-2.62M
65.09%-1.93M
-120.96%-3.76M
43.04%-13.58M
30.05%-4.26M
61.48%-2.09M
20.94%-5.53M
68.05%-1.7M
-17.53%-23.85M
17.64%-6.09M
Minority interest income
Net income attributable to the parent company
-24.99%-2.62M
65.09%-1.93M
-120.96%-3.76M
43.04%-13.58M
30.05%-4.26M
61.48%-2.09M
20.94%-5.53M
68.05%-1.7M
-17.53%-23.85M
17.64%-6.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-24.99%-2.62M
65.09%-1.93M
-120.96%-3.76M
43.04%-13.58M
30.05%-4.26M
61.48%-2.09M
20.94%-5.53M
68.05%-1.7M
-17.53%-23.85M
17.64%-6.09M
Basic earnings per share
77.14%-0.4
87.01%-0.6
5.23%-1.63
56.99%-11.14
39.00%-3.05
72.66%-1.75
44.00%-4.62
72.48%-1.72
-7.92%-25.9
41.18%-5
Diluted earnings per share
77.14%-0.4
87.01%-0.6
5.23%-1.63
56.99%-11.14
39.00%-3.05
72.66%-1.75
44.00%-4.62
72.48%-1.72
-7.92%-25.9
41.18%-5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 16.93%3.86M19.41%4.05M-11.36%3.42M-13.87%13.8M-17.77%3.25M-22.26%3.3M-18.86%3.4M5.85%3.86M-5.10%16.02M-10.10%3.95M
Operating revenue 16.93%3.86M19.41%4.05M-11.36%3.42M-13.87%13.8M-17.77%3.25M-22.26%3.3M-18.86%3.4M5.85%3.86M-5.10%16.02M-10.10%3.95M
Cost of revenue -1.80%1.53M8.17%1.4M-2.50%1.48M-7.91%5.53M-25.99%1.16M-11.20%1.55M-18.73%1.3M39.07%1.52M40.27%6.01M21.68%1.57M
Gross profit 33.60%2.33M26.36%2.65M-17.12%1.94M-17.45%8.27M-12.37%2.09M-30.01%1.75M-18.93%2.1M-8.39%2.34M-20.51%10.02M-23.27%2.38M
Operating expense -7.57%4.98M-30.66%4.59M-22.06%5.72M-27.06%25.57M-26.34%6.22M-31.84%5.39M-30.75%6.62M-20.11%7.34M9.28%35.05M-12.07%8.45M
Selling and administrative expenses -7.71%4.83M-31.31%4.44M-22.20%5.58M-27.44%24.95M-26.64%6.07M-32.23%5.24M-31.13%6.47M-20.61%7.17M9.70%34.38M-12.30%8.28M
-Selling and marketing expense -46.02%346K-45.76%320K3.97%655K-53.80%2.47M-55.28%606K-42.04%641K-65.27%590K-16.33%630K-3.80%5.34M2.89%1.36M
-General and administrative expense -2.37%4.49M-29.86%4.12M-24.72%4.92M-22.60%22.48M-21.03%5.47M-30.59%4.6M-23.59%5.88M-21.00%6.54M12.60%29.04M-14.76%6.92M
Depreciation amortization depletion -2.67%146K-2.03%145K-16.57%146K-7.17%621K-11.83%149K-14.29%150K-8.64%148K8.02%175K-8.73%669K0.60%169K
-Depreciation and amortization -2.67%146K-2.03%145K-16.57%146K-7.17%621K-11.83%149K-14.29%150K-8.64%148K8.02%175K-8.73%669K0.60%169K
Operating profit 27.34%-2.65M57.14%-1.94M24.38%-3.79M30.90%-17.3M31.83%-4.13M32.68%-3.64M35.14%-4.52M24.61%-5.01M-28.56%-25.03M6.72%-6.06M
Net non-operating interest income expense
Other net income (expense) -98.13%29K100.59%6K-99.33%22K213.07%3.71M-384.62%-126K5,829.63%1.55M-3,510.71%-1.01M152.45%3.3M247.70%1.19M97.04%-26K
Gain on sale of security --------------3.78M---131K--1.6M---867K--3.18M--------
Special income (charges) --------------0----------------241.27%1.29M102.41%22K
-Less:Other special charges -----------------------------------1.29M---22K
Other non- operating income (expenses) 154.72%29K104.17%6K-82.68%22K35.64%-65K110.42%5K-96.30%-53K-414.29%-144K504.76%127K-193.52%-101K-250.00%-48K
Income before tax -24.99%-2.62M65.09%-1.93M-120.96%-3.76M43.04%-13.58M30.05%-4.26M61.48%-2.09M20.94%-5.53M68.05%-1.7M-17.53%-23.85M17.64%-6.09M
Income tax
Net income -24.99%-2.62M65.09%-1.93M-120.96%-3.76M43.04%-13.58M30.05%-4.26M61.48%-2.09M20.94%-5.53M68.05%-1.7M-17.53%-23.85M17.64%-6.09M
Net income continuous Operations -24.99%-2.62M65.09%-1.93M-120.96%-3.76M43.04%-13.58M30.05%-4.26M61.48%-2.09M20.94%-5.53M68.05%-1.7M-17.53%-23.85M17.64%-6.09M
Minority interest income
Net income attributable to the parent company -24.99%-2.62M65.09%-1.93M-120.96%-3.76M43.04%-13.58M30.05%-4.26M61.48%-2.09M20.94%-5.53M68.05%-1.7M-17.53%-23.85M17.64%-6.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -24.99%-2.62M65.09%-1.93M-120.96%-3.76M43.04%-13.58M30.05%-4.26M61.48%-2.09M20.94%-5.53M68.05%-1.7M-17.53%-23.85M17.64%-6.09M
Basic earnings per share 77.14%-0.487.01%-0.65.23%-1.6356.99%-11.1439.00%-3.0572.66%-1.7544.00%-4.6272.48%-1.72-7.92%-25.941.18%-5
Diluted earnings per share 77.14%-0.487.01%-0.65.23%-1.6356.99%-11.1439.00%-3.0572.66%-1.7544.00%-4.6272.48%-1.72-7.92%-25.941.18%-5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data